Literature DB >> 19193654

Etiologies of delirium and their relationship to reversibility and motor subtype in cancer patients.

Ryuichi Sagawa1, Tatsuo Akechi, Toru Okuyama, Megumi Uchida, Toshiaki A Furukawa.   

Abstract

BACKGROUND: Delirium is one of the most commonly encountered complications in patients with cancer. The etiology of delirium in cancer is often multi-factorial, and few reports have examined the causes of delirium. This study investigated the causes of delirium and their association with reversibility and motor subtypes of delirium in cancer patients.
METHODS: The subjects were inpatients with cancer who had been referred to our Department of Psychiatry and diagnosed with delirium by psychiatrists. The causes of delirium were determined using standard operationalized criteria. The association between delirium reversibility and each clinical factor was examined in detail and longitudinally.
RESULTS: Data were available from a total of 100 patients. Among them, 58% had hyperactive delirium and 14% had hypoactive delirium. Delirium improved in 56% of the patients after 1 week of standard treatment. The most frequent causes of delirium were opioids (29%), inflammation (27%), dehydration and/or sodium level abnormalities (15%). While two or more causes were identified in 40% or more of the cases, the cause of delirium was not identified in 20% of the patients. Neither reversibility nor motor subtypes of delirium was associated with any specific etiological factor.
CONCLUSIONS: When treating delirium, prevalences of the causes of delirium, as identified in this study, should be kept in mind. Further research is required to investigate what specific treatments may facilitate the prompt recovery from delirium among cancer patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19193654     DOI: 10.1093/jjco/hyn157

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  11 in total

1.  Pre- and post-transplantation risk factors for delirium onset and severity in patients undergoing hematopoietic stem-cell transplantation.

Authors:  Jesse R Fann; Rebecca A Hubbard; Catherine M Alfano; Sari Roth-Roemer; Wayne J Katon; Karen L Syrjala
Journal:  J Clin Oncol       Date:  2011-01-24       Impact factor: 44.544

2.  Impact of pneumonia on hyperactive delirium in end-stage lung cancer patients.

Authors:  Hidekazu Suzuki; Tomonori Hirashima; Masashi Kobayashi; Norio Okamoto; Yuka Matsuura; Motohiro Tamiya; Naoko Morishita; Kohei Okafuji; Takayuki Shiroyama; Osamu Morimura; Satomu Morita; Ichiro Kawase
Journal:  Support Care Cancer       Date:  2012-06-19       Impact factor: 3.603

3.  Comparative Study of Delirium in Emergency and Consultation Liaison- A Tertiary Care Hospital Based Study in Northern India.

Authors:  Arvind Sharma
Journal:  J Clin Diagn Res       Date:  2016-08-01

Review 4.  Delirium in patients with cancer: assessment, impact, mechanisms and management.

Authors:  Peter G Lawlor; Shirley H Bush
Journal:  Nat Rev Clin Oncol       Date:  2014-09-02       Impact factor: 66.675

5.  An analytical framework for delirium research in palliative care settings: integrated epidemiologic, clinician-researcher, and knowledge user perspectives.

Authors:  Peter G Lawlor; Daniel H J Davis; Mohammed Ansari; Annmarie Hosie; Salmaan Kanji; Franco Momoli; Shirley H Bush; Sharon Watanabe; David C Currow; Bruno Gagnon; Meera Agar; Eduardo Bruera; David J Meagher; Sophia E J A de Rooij; Dimitrios Adamis; Augusto Caraceni; Katie Marchington; David J Stewart
Journal:  J Pain Symptom Manage       Date:  2014-04-12       Impact factor: 3.612

6.  Risk factors for delirium in patients undergoing hematopoietic stem cell transplantation.

Authors:  Michelle T Weckmann; Roger Gingrich; James A Mills; Larry Hook; Leigh J Beglinger
Journal:  Ann Clin Psychiatry       Date:  2012-08       Impact factor: 1.567

7.  Outcome Differences by Delirium Motor Subtype in Patients with Ischemic Stroke.

Authors:  Hee Won Yang; Miji Lee; Jong Wook Shin; Hye Seon Jeong; Jei Kim; Jeong Lan Kim
Journal:  Psychiatry Investig       Date:  2019-10-28       Impact factor: 2.505

8.  How do delirium motor subtypes differ in phenomenology and contributory aetiology? a cross-sectional, multisite study of liaison psychiatry and palliative care patients.

Authors:  Kevin Glynn; Frank McKenna; Kevin Lally; Muireann O'Donnell; Sandeep Grover; Subho Chakrabarti; Ajit Avasthi; Surendra K Mattoo; Akhilesh Sharma; Abhishek Gosh; Ruchita Shah; David Hickey; James Fitzgerald; Brid Davis; Niamh O'Regan; Dimitrious Adamis; Olugbenja Williams; Fahad Awan; C Dunne; Walter Cullen; Shane McInerney; John McFarland; Faiza Jabbar; Henry O'Connell; Paula T Trzepacz; Maeve Leonard; David Meagher
Journal:  BMJ Open       Date:  2021-04-14       Impact factor: 2.692

Review 9.  Recent Insights on Prevalence and Corelations of Hypoactive Delirium.

Authors:  Vaios Peritogiannis; Maria Bolosi; Charalampos Lixouriotis; Dimitrios V Rizos
Journal:  Behav Neurol       Date:  2015-08-10       Impact factor: 3.342

10.  JPOS/JASCC clinical guidelines for delirium in adult cancer patients: a summary of recommendation statements.

Authors:  Yoshinobu Matsuda; Hitoshi Tanimukai; Shinichiro Inoue; Shuji Inada; Koji Sugano; Hideaki Hasuo; Masafumi Yoshimura; Saho Wada; Chikako Dotani; Hiroyoshi Adachi; Yoshiaki Okamoto; Mari Takeuchi; Daisuke Fujisawa; Jun Kako; Chiyuki Sasaki; Yasuhiro Kishi; Nobuya Akizuki; Masatoshi Inagaki; Yosuke Uchitomi; Eisuke Matsushima; Toru Okuyama
Journal:  Jpn J Clin Oncol       Date:  2020-05-05       Impact factor: 3.019

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.